Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Judy Wang, MD
SCRI - Florida Cancer Specialists - Sarasota Cattlemen Office (Coordinating Investigator)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Honorhealth Research Institute
Scottsdale, Arizona, United States
- University of California Los Angeles
Los Angeles, California, United States
- Pacific Hematology Oncology Associates
San Francisco, California, United States
- the Angeles Clinic and Research Institute - West Los Angeles Office
Santa Monica, California, United States
- University of California Los Angeles
Santa Monica, California, United States
- Florida Cancer Specialists
Sarasota, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- the University of Chicago
Chicago, Illinois, United States
- Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Washington University School of Medicine Siteman Cancer Center
St Louis, Missouri, United States
- John Theurer Cancer Center
Hackensack, New Jersey, United States
- New York University Medical Oncology Associates
New York, New York, United States
- Weill Cornell Medicine
New York, New York, United States
- Upmc Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
- the Miriam Hospital
Providence, Rhode Island, United States
- Baylor Scott and White Center for Advanced Heart and Lung Disese
Dallas, Texas, United States
- Huntsman Cancer Institute and Hospital
Salt Lake City, Utah, United States
- Swedish Medical Oncology - First Hill
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Jan 2020
- Primary completion
- 26 Aug 2021
- Completion
- 23 Feb 2023
- Last update posted
- 27 Oct 2025
- Registered enrollment
- 56
- Registry id
- NCT04208958
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.